메뉴 건너뛰기




Volumn 9, Issue 1 S, 2011, Pages 325-332

Atherothrombosis and the role of antiplatelet therapy

Author keywords

Acute coronary syndromes; Antiplatelet therapy; Aspirin; Atherothrombosis; Peripheral artery disease; Stroke

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ATOPAXAR; CANGRELOR; CILOSTAZOL; CLOPIDOGREL; CYCLOOXYGENASE 1; CYTOCHROME P450; DIPYRIDAMOLE; ELINOGREL; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; IFETROBAN; PRASUGREL; PROTEINASE ACTIVATED RECEPTOR; SULOTROBAN; TERUTROBAN; THROMBIN; TICAGRELOR; TICLOPIDINE; TIROFIBAN; TRIFLUSAL; VORAPAXAR;

EID: 79960648125     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04277.x     Document Type: Review
Times cited : (23)

References (65)
  • 1
    • 33846404966 scopus 로고    scopus 로고
    • Expanding priorities - confronting chronic disease in countries with low income
    • Anderson GF, Chu E. Expanding priorities - confronting chronic disease in countries with low income. N Engl J Med 2007; 356: 209-11.
    • (2007) N Engl J Med , vol.356 , pp. 209-211
    • Anderson, G.F.1    Chu, E.2
  • 4
    • 77950938605 scopus 로고    scopus 로고
    • Prevalence of asymptomatic coronary artery disease in ischemic stroke patients: the PRECORIS study
    • Calvet D, Touzé E, Varenne O, Sablayrolles J, Weber S, Mas J. Prevalence of asymptomatic coronary artery disease in ischemic stroke patients: the PRECORIS study. Circulation 2010; 121: 1623-9.
    • (2010) Circulation , vol.121 , pp. 1623-1629
    • Calvet, D.1    Touzé, E.2    Varenne, O.3    Sablayrolles, J.4    Weber, S.5    Mas, J.6
  • 6
    • 42649136576 scopus 로고    scopus 로고
    • Prevalence of coronary artery disease in Japanese patients with cerebral infarction: impact of metabolic syndrome and intracranial large artery atherosclerosis
    • Hoshino A, Nakamura T, Enomoto S, Kawahito H, Kurata H, Nakahara Y, Ijichi T. Prevalence of coronary artery disease in Japanese patients with cerebral infarction: impact of metabolic syndrome and intracranial large artery atherosclerosis. Circ J 2008; 72: 404-8.
    • (2008) Circ J , vol.72 , pp. 404-408
    • Hoshino, A.1    Nakamura, T.2    Enomoto, S.3    Kawahito, H.4    Kurata, H.5    Nakahara, Y.6    Ijichi, T.7
  • 7
    • 0028342542 scopus 로고
    • Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women > or = 62years of age
    • Aronow WS, Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women > or = 62years of age. Am J Cardiol 1994; 74: 64-5.
    • (1994) Am J Cardiol , vol.74 , pp. 64-65
    • Aronow, W.S.1    Ahn, C.2
  • 9
    • 37249068049 scopus 로고    scopus 로고
    • Platelet activation and atherothrombosis
    • Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007; 357: 2482-94.
    • (2007) N Engl J Med , vol.357 , pp. 2482-2494
    • Davì, G.1    Patrono, C.2
  • 11
    • 11144246091 scopus 로고    scopus 로고
    • Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials
    • on behalf of the Dipyridamole in Stroke Collaboration.
    • Leonardi-Bee J, Bath PM, Bousser M, Davalos A, Diener H, Guiraud-Chaumeil B, Sivenius J, Yatsu F, Dewey ME, on behalf of the Dipyridamole in Stroke Collaboration. Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials. Stroke 2005; 36: 162-8.
    • (2005) Stroke , vol.36 , pp. 162-168
    • Leonardi-Bee, J.1    Bath, P.M.2    Bousser, M.3    Davalos, A.4    Diener, H.5    Guiraud-Chaumeil, B.6    Sivenius, J.7    Yatsu, F.8    Dewey, M.E.9
  • 12
    • 0037114872 scopus 로고    scopus 로고
    • Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication
    • Thompson PD, Zimet R, Forbes WP, Zhang P. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication. Am J Cardiol 2002; 90: 1314-9.
    • (2002) Am J Cardiol , vol.90 , pp. 1314-1319
    • Thompson, P.D.1    Zimet, R.2    Forbes, W.P.3    Zhang, P.4
  • 13
    • 77953661111 scopus 로고    scopus 로고
    • Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction/clinical perspective
    • Jeong Y, Hwang J, Kim I, Park Y, Hwang S, Lee S, Kwak CH, Park S. Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction/clinical perspective. Circ Cardiovasc Interv 2010; 3: 17-26.
    • (2010) Circ Cardiovasc Interv , vol.3 , pp. 17-26
    • Jeong, Y.1    Hwang, J.2    Kim, I.3    Park, Y.4    Hwang, S.5    Lee, S.6    Kwak, C.H.7    Park, S.8
  • 16
    • 33749339075 scopus 로고    scopus 로고
    • Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects
    • Hulot J, Bura A, Villard E, Azizi M, Remones V, Goyenvalle C, Aiach M, Lechat P, Gaussem P. Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects. Blood 2006; 108: 2244-7.
    • (2006) Blood , vol.108 , pp. 2244-2247
    • Hulot, J.1    Bura, A.2    Villard, E.3    Azizi, M.4    Remones, V.5    Goyenvalle, C.6    Aiach, M.7    Lechat, P.8    Gaussem, P.9
  • 19
    • 34250714831 scopus 로고    scopus 로고
    • The greater in vivo antiplatelet effects of prasugrel as compared to clopidogrel reflect more efficient generation of its active metabolite with similar antiplatelet activity to that of clopidogrel's active metabolite
    • Sugidachi A, Ogawa T, Kurihara A, Hagihara K, Jakubowski JA, Hashimoto M, Niitsu Y, Asai F. The greater in vivo antiplatelet effects of prasugrel as compared to clopidogrel reflect more efficient generation of its active metabolite with similar antiplatelet activity to that of clopidogrel's active metabolite. J Thromb Haemost 2007; 5: 1545-51.
    • (2007) J Thromb Haemost , vol.5 , pp. 1545-1551
    • Sugidachi, A.1    Ogawa, T.2    Kurihara, A.3    Hagihara, K.4    Jakubowski, J.A.5    Hashimoto, M.6    Niitsu, Y.7    Asai, F.8
  • 20
    • 77955677366 scopus 로고    scopus 로고
    • Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y(12)-receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Efficacy in nonurgent Percutaneous Coronary Interventions patients (INNOVATE-PCI)
    • Leonardi S, Rao SV, Harrington RA, Bhatt DL, Gibson CM, Roe MT, Kochman J, Huber K, Zeymer U, Madan M, Gretler DD, McClure MW, Paynter GE, Thompson V, Welsh RC. Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y(12)-receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Efficacy in nonurgent Percutaneous Coronary Interventions patients (INNOVATE-PCI). Am Heart J 2010; 160: 65-72.
    • (2010) Am Heart J , vol.160 , pp. 65-72
    • Leonardi, S.1    Rao, S.V.2    Harrington, R.A.3    Bhatt, D.L.4    Gibson, C.M.5    Roe, M.T.6    Kochman, J.7    Huber, K.8    Zeymer, U.9    Madan, M.10    Gretler, D.D.11    McClure, M.W.12    Paynter, G.E.13    Thompson, V.14    Welsh, R.C.15
  • 21
    • 73949157474 scopus 로고    scopus 로고
    • Platelet thrombin receptor antagonism and atherothrombosis
    • Angiolillo DJ, Capodanno D, Goto S. Platelet thrombin receptor antagonism and atherothrombosis. Eur Heart J 2010; 31: 17-28.
    • (2010) Eur Heart J , vol.31 , pp. 17-28
    • Angiolillo, D.J.1    Capodanno, D.2    Goto, S.3
  • 22
    • 28344436780 scopus 로고    scopus 로고
    • Protease-activated receptors in hemostasis, thrombosis and vascular biology
    • Coughlin SR. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 2005; 3: 1800-14.
    • (2005) J Thromb Haemost , vol.3 , pp. 1800-1814
    • Coughlin, S.R.1
  • 24
    • 67749086022 scopus 로고    scopus 로고
    • The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease
    • Serebruany VL, Kogushi M, Dastros-Pitei D, Flather M, Bhatt DL. The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease. Thromb Haemost 2009; 102: 111-9.
    • (2009) Thromb Haemost , vol.102 , pp. 111-119
    • Serebruany, V.L.1    Kogushi, M.2    Dastros-Pitei, D.3    Flather, M.4    Bhatt, D.L.5
  • 25
    • 78149355554 scopus 로고    scopus 로고
    • Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease
    • Goto S, Ogawa H, Takeuchi M, Flather MD, Bhatt DL. Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease. Eur Heart J 2010; 31: 2601-13.
    • (2010) Eur Heart J , vol.31 , pp. 2601-2613
    • Goto, S.1    Ogawa, H.2    Takeuchi, M.3    Flather, M.D.4    Bhatt, D.L.5
  • 28
    • 0037065502 scopus 로고    scopus 로고
    • Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
    • Antithrombotic Trialists' Collaboration.
    • Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71-86.
    • (2002) BMJ , vol.324 , pp. 71-86
  • 29
    • 65849268320 scopus 로고    scopus 로고
    • Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
    • Antithrombotic Trialists' (ATT) Collaboration
    • Antithrombotic Trialists' (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009; 373: 1849-60.
    • (2009) Lancet , vol.373 , pp. 1849-1860
  • 30
    • 27644531361 scopus 로고    scopus 로고
    • Early intravenous then oral metoprolol in 45852 patients with acute myocardial infarction: randomised placebo-controlled trial
    • COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group.
    • Chen ZM, Pan HC, Chen YP, Peto R, Collins R, Jiang LX, Xie JX, Liu LS; COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Early intravenous then oral metoprolol in 45852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005; 366: 1622-32.
    • (2005) Lancet , vol.366 , pp. 1622-1632
    • Chen, Z.M.1    Pan, H.C.2    Chen, Y.P.3    Peto, R.4    Collins, R.5    Jiang, L.X.6    Xie, J.X.7    Liu, L.S.8
  • 33
    • 34547655744 scopus 로고    scopus 로고
    • ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with
    • Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007; 50: e1-157.
    • (2007) J Am Coll Cardiol , vol.50
    • Anderson, J.L.1    Adams, C.D.2    Antman, E.M.3    Bridges, C.R.4    Califf, R.M.5    Casey, D.E.6    Chavey, W.E.7    Fesmire, F.M.8    Hochman, J.S.9    Levin, T.N.10    Lincoff, A.M.11    Peterson, E.D.12    Theroux, P.13    Wenger, N.K.14    Wright, R.S.15    Smith, S.C.16    Jacobs, A.K.17    Adams, C.D.18    Anderson, J.L.19    Antman, E.M.20    more..
  • 34
    • 45949090749 scopus 로고    scopus 로고
    • Antithrombotic Therapy for Non-ST-Segment Elevation Acute Coronary Syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
    • Harrington RA, Becker RC, Cannon CP, Gutterman D, Lincoff AM, Popma JJ, Steg G, Guyatt GH, Goodman SG. Antithrombotic Therapy for Non-ST-Segment Elevation Acute Coronary Syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 670S-707S.
    • (2008) Chest , vol.133
    • Harrington, R.A.1    Becker, R.C.2    Cannon, C.P.3    Gutterman, D.4    Lincoff, A.M.5    Popma, J.J.6    Steg, G.7    Guyatt, G.H.8    Goodman, S.G.9
  • 36
    • 77958005516 scopus 로고    scopus 로고
    • Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial
    • Mehta SR, Tanguay J, Eikelboom JW, Jolly SS, Joyner CD, Granger CB, Faxon DP, Rupprecht H, Budaj A, Avezum A. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Lancet 2010; 376: 1233-43.
    • (2010) Lancet , vol.376 , pp. 1233-1243
    • Mehta, S.R.1    Tanguay, J.2    Eikelboom, J.W.3    Jolly, S.S.4    Joyner, C.D.5    Granger, C.B.6    Faxon, D.P.7    Rupprecht, H.8    Budaj, A.9    Avezum, A.10
  • 38
    • 77955690680 scopus 로고    scopus 로고
    • Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial
    • e1.
    • Chin CT, Roe MT, Fox KAA, Prabhakaran D, Marshall DA, Petitjean H, Lokhnygina Y, Brown E, Armstrong PW, White HD, Ohman EM. Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial. Am Heart J 2010; 160: 16-22.e1.
    • (2010) Am Heart J , vol.160 , pp. 16-22
    • Chin, C.T.1    Roe, M.T.2    Fox, K.A.A.3    Prabhakaran, D.4    Marshall, D.A.5    Petitjean, H.6    Lokhnygina, Y.7    Brown, E.8    Armstrong, P.W.9    White, H.D.10    Ohman, E.M.11
  • 45
    • 85058720552 scopus 로고    scopus 로고
    • The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA•CER) trial: study design and rationale
    • The TRA•CER Executive and Steering committee. e4.
    • The TRA•CER Executive and Steering committee. The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA•CER) trial: study design and rationale. Am Heart J 2009; 158: 327-34.e4.
    • (2009) Am Heart J , vol.158 , pp. 327-334
  • 48
    • 0030590746 scopus 로고    scopus 로고
    • A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
    • CAPRIE Steering Committee.
    • CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-39.
    • (1996) Lancet , vol.348 , pp. 1329-1339
  • 52
    • 76449090664 scopus 로고    scopus 로고
    • Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events
    • Hankey GJ, Eikelboom J. Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events. Lancet Neurol 2010; 9: 273-84.
    • (2010) Lancet Neurol , vol.9 , pp. 273-284
    • Hankey, G.J.1    Eikelboom, J.2
  • 53
    • 65449173947 scopus 로고    scopus 로고
    • The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population
    • Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, Hennerici M, Mattle HP, Rothwell PM. The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population. Cerebrovasc Dis 2009; 27: 608-13.
    • (2009) Cerebrovasc Dis , vol.27 , pp. 608-613
    • Bousser, M.G.1    Amarenco, P.2    Chamorro, A.3    Fisher, M.4    Ford, I.5    Fox, K.6    Hennerici, M.7    Mattle, H.P.8    Rothwell, P.M.9
  • 57
    • 35248821708 scopus 로고    scopus 로고
    • Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial
    • FASTER Investigators.
    • Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM, FASTER Investigators. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol 2007; 6: 961-9.
    • (2007) Lancet Neurol , vol.6 , pp. 961-969
    • Kennedy, J.1    Hill, M.D.2    Ryckborst, K.J.3    Eliasziw, M.4    Demchuk, A.M.5    Buchan, A.M.6
  • 58
    • 5444220166 scopus 로고    scopus 로고
    • Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease
    • Tran H, Anand SS. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. JAMA 2004; 292: 1867-74.
    • (2004) JAMA , vol.292 , pp. 1867-1874
    • Tran, H.1    Anand, S.S.2
  • 59
    • 65549105821 scopus 로고    scopus 로고
    • Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials
    • Berger JS, Krantz MJ, Kittelson JM, Hiatt WR. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. JAMA 2009; 301: 1909-19.
    • (2009) JAMA , vol.301 , pp. 1909-1919
    • Berger, J.S.1    Krantz, M.J.2    Kittelson, J.M.3    Hiatt, W.R.4
  • 64
    • 35348816110 scopus 로고    scopus 로고
    • Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins
    • De Berardis G, Sacco M, Evangelista V, Filippi A, Giorda CB, Tognoni G, Valentini U, Nicolucci A. Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins. Trials 2007; 8: 21.
    • (2007) Trials , vol.8 , pp. 21
    • De Berardis, G.1    Sacco, M.2    Evangelista, V.3    Filippi, A.4    Giorda, C.B.5    Tognoni, G.6    Valentini, U.7    Nicolucci, A.8
  • 65
    • 79960623280 scopus 로고    scopus 로고
    • British Heart Foundation. ASCEND: a study of cardiovascular events in diabetes. Accessed 28 April 2011.
    • British Heart Foundation. ASCEND: a study of cardiovascular events in diabetes. Accessed 28 April 2011.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.